Show simple item record

dc.contributor.authorNehl, Eric J.
dc.contributor.authorSimin, Karl J.
dc.contributor.authorHafer, Nathaniel
dc.contributor.authorMcManus, David D.
dc.date2022-08-11T08:09:59.000
dc.date.accessioned2022-08-23T16:51:06Z
dc.date.available2022-08-23T16:51:06Z
dc.date.issued2021-04-28
dc.date.submitted2021-05-03
dc.identifier.citation<p>E. J. Nehl et al., "The RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change," in IEEE Open Journal of Engineering in Medicine and Biology, vol. 2, pp. 142-151, 2021, doi: 10.1109/OJEMB.2021.3070825. <a href="https://doi.org/10.1109/OJEMB.2021.3070825" target="_blank" title="view article on publisher's site">View article on publisher's site</a></p>
dc.identifier.doi10.1109/OJEMB.2021.3070825
dc.identifier.pmid34192286
dc.identifier.urihttp://hdl.handle.net/20.500.14038/41793
dc.description<p>Full author list omitted for brevity. For the full list of authors, see article.</p>
dc.description.abstractFaced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the “RADx SM Tech Test Verification Core” and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to preserve lives and facilitate the safe return to work and school. Focal points included: laboratory and clinical device evaluation of the limit of viral detection, sensitivity, and specificity of devices in controlled and community settings; regulatory expertise to provide focused attention to barriers to device approval and distribution; usability testing from the perspective of patients and those using the tests to identify and overcome device limitations, and engineering assessment to evaluate robustness of design including human factors, manufacturability, and scalability.
dc.language.isoen_US
dc.rightsThis work is licensed under a Creative Commons Attribution 4.0 License. For more information, see https://creativecommons.org/licenses/by/4.0/
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectCOVID-19
dc.subjectDevice Testing
dc.subjectRADx
dc.subjectUMCCTS funding
dc.subjectBiomedical Engineering and Bioengineering
dc.subjectDiagnosis
dc.subjectHealth Services Administration
dc.subjectInfectious Disease
dc.subjectTranslational Medical Research
dc.subjectVirus Diseases
dc.titleThe RADx Tech Test Verification Core and the ACME POCT in the Evaluation of COVID-19 Testing Devices: A Model for Progress and Change
dc.typeJournal Article
dc.source.journaltitleIEEE Open Journal of Engineering in Medicine and Biology
dc.source.volume2
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=5610&amp;context=oapubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/oapubs/4593
dc.identifier.contextkey22764544
refterms.dateFOA2022-08-23T16:51:06Z
html.description.abstract<p>Faced with the COVID-19 pandemic, the US system for developing and testing technologies was challenged in unparalleled ways. This article describes the multi-institutional, transdisciplinary team of the “RADx <sup>SM</sup> Tech Test Verification Core” and its role in expediting evaluations of COVID-19 testing devices. Expertise related to aspects of diagnostic testing was coordinated to evaluate testing devices with the goal of significantly expanding the ability to mass screen Americans to preserve lives and facilitate the safe return to work and school. Focal points included: laboratory and clinical device evaluation of the limit of viral detection, sensitivity, and specificity of devices in controlled and community settings; regulatory expertise to provide focused attention to barriers to device approval and distribution; usability testing from the perspective of patients and those using the tests to identify and overcome device limitations, and engineering assessment to evaluate robustness of design including human factors, manufacturability, and scalability.</p>
dc.identifier.submissionpathoapubs/4593
dc.contributor.departmentDepartment of Medicine, Division of Cardiovascular Medicine
dc.contributor.departmentUMass Center for Clinical and Translational Science
dc.contributor.departmentDepartment of Molecular, Cell, and Cancer Biology
dc.source.pages142-151


Files in this item

Thumbnail
Name:
09418534.pdf
Size:
1.085Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

This work is licensed under a Creative Commons Attribution 4.0 License. For more information, see https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as This work is licensed under a Creative Commons Attribution 4.0 License. For more information, see https://creativecommons.org/licenses/by/4.0/